The Women’s Tennis Association (WTA) announces a policy change for athletes seeking to compete in the women’s professional category. According to reports, the WTA is moving away from a prior eligibility approach that used testosterone limits and is replacing it with mandatory SRY gene testing. Both outlets describe the SRY test as the new standard intended to determine eligibility for women’s competition and to address concerns about maintaining fair competition.
The SRY gene is associated with male sex development, and the policy framing in the reports emphasizes “equal” or “fair” athletic competition. The New York Post also places the WTA decision within a broader pattern, stating that other sports organizations, including World Athletics and World Boxing, have implemented or are implementing similar SRY gene testing requirements.
Fox News and the New York Post both characterize the change as an adoption of genetic testing for entry into the women’s category, rather than relying on testosterone limits alone. The reporting does not include details on timing, testing procedures, or specific eligibility thresholds beyond the shift to SRY gene testing.
